Novel biocompatible microparticles can be created using heat and light
Scientists have demonstrated an innovative technique for creating microparticles for tissue engineering out of a combination of disordered and partially ordered proteins.
List view / Grid view
Scientists have demonstrated an innovative technique for creating microparticles for tissue engineering out of a combination of disordered and partially ordered proteins.
CRISPR is a tool used by researchers to precisely edit genes and has shown potential for treating genetic diseases. This article delves into some recent developments and explores what the future holds for CRISPR.
A pharmaceutical target has been identified by Duke University that, when activated, can reverse bone degradation caused by osteoporosis.
A new study has found a small molecule which prevents cancer cells from mutating and becoming resistant to chemotherapy.
Distinguishing whether bacteria are resistant to antibiotics or resilient to them is hugely important in determining the success of the treatment...
The protein ASTN2 has been identified as a trafficking protein that ushers proteins away from the membrane ready for degradation in the cell...
Researchers have identified a key in the road for the way the liver deals with carbohydrates, fats and protein...
Researchers in the United States have developed improved methods for capturing circulating tumour cells (CTCs) on clinical samples, with a view to assessing treatment for cancer patients and screening for the disease.
First functioning human muscle grown from induced pluripotent stem cells holds promise for cellular therapies, drug discovery and studying rare diseases...
Researchers have developed a vaccine candidate that spurs animals to produce antibodies against protective sugars of multiple HIV strains...
Viruses are notorious for taking over their host's operations and using them to their own advantage. But few human viruses make themselves quite as cozy as the Epstein-Barr virus, which can be found in an estimated 9/10 humans without causing any ill effects. That is, until this virus causes mononucleosis…
Viking Therapeutics announced positive initial results from a proof-of-concept study of VK2809 in an in vivo model of glycogen storage disease Ia (GSD Ia).
2 June 2016 | By Victoria White, Digital Content Producer
Fasnall appears to impede a process that fuels breast cancer in mice, a discovery that could have implications in the treatment of a host of cancers...
1 June 2016 | By Victoria White, Digital Content Producer
In a study, the compound 16-8 also quelled pain in living animals, including abdominal aches in mice with pancreas inflammation...
25 May 2016 | By Victoria White, Digital Content Producer
Scientists have identified a molecular key that breast cancer cells use to invade bone marrow in mice, where they may be protected from therapies...